In vitro and in vivo studies showed that the conjugated PTX, RAP or MIX–M micelles led to the treatment of ovarian cancer through both cytotoxic effects to cancer cells and simultaneous angiogenesis inhibition. This evidence concerns the gene LRPAP1 and ovarian carcinoma.